MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$205,194K
(238.27%↑ Y/Y)
Marketable securities
$175,685K
(18770.57%↑ Y/Y)
Accounts receivable, net
$43,271K
(154.10%↑ Y/Y)
Prepaid expenses and
other current...
$26,182K
(33.27%↑ Y/Y)
Prepaid expenses and
other current...
$2,071K
(2.07%↑ Y/Y)
Inventories
$547K
(-93.52%↓ Y/Y)
Due from related
parties-Related Party
$3K
(-99.29%↓ Y/Y)
Total current assets
$452,953K
(314.93%↑ Y/Y)
Property, plant and
equipment, net
$112,785K
(-16.62%↓ Y/Y)
Operating lease
right-of-use assets,...
$20,573K
(24.82%↑ Y/Y)
Long-term inventories
$18,856K
Other
assets-Nonrelated Party
$15,746K
(247.36%↑ Y/Y)
Non-marketable equity
investment
$12,885K
(-16.56%↓ Y/Y)
Operating lease
right-of-use assets,...
$12,461K
(-18.54%↓ Y/Y)
Other assets-Related
Party
$378K
(0.00%↑ Y/Y)
Accumulated deficit
-$4,359,428K
(-24.38%↓ Y/Y)
Total assets
$646,637K
(112.88%↑ Y/Y)
Total immunitybio
stockholders deficit
-$870,006K
(-47.10%↓ Y/Y)
Additional paid-in capital
$3,461,865K
(19.65%↑ Y/Y)
Accumulated other
comprehensive income
$27,453K
(37.57%↑ Y/Y)
Common stock, 0.0001
par value...
$104K
(22.35%↑ Y/Y)
Total liabilities and
stockholders deficit
$646,637K
(112.88%↑ Y/Y)
Total stockholders
deficit
-$869,126K
(-47.19%↓ Y/Y)
Noncontrolling interests
$880K
(-7.27%↓ Y/Y)
Total liabilities
$1,515,763K
(69.50%↑ Y/Y)
Related-party convertible
note payable, at fair...
$678,386K
(39.67%↑ Y/Y)
Revenue interest
liability
$404,299K
(36.46%↑ Y/Y)
Warrant liabilities
$308,193K
(3315.64%↑ Y/Y)
Total current
liabilities
$67,952K
(38.10%↑ Y/Y)
Derivative liabilities
$23,314K
(13.49%↑ Y/Y)
Operating lease
liabilities, less current...
$20,062K
(17.48%↑ Y/Y)
Operating lease
liabilities, less current...
$13,085K
(-18.32%↓ Y/Y)
Other liabilities
$472K
(27.57%↑ Y/Y)
Accrued expenses and
other liabilities
$48,204K
(72.84%↑ Y/Y)
Accounts
payable-Nonrelated Party
$11,192K
(-17.10%↓ Y/Y)
Operating lease
liabilities-Nonrelated Party
$4,690K
(21.00%↑ Y/Y)
Operating lease
liabilities-Related Party
$2,936K
(-18.08%↓ Y/Y)
Accounts
payable-Related Party
$930K
(161.97%↑ Y/Y)
Back
Back
Balance Sheet
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
ImmunityBio-logo-inverted-svg-svg
source: myfinsight.com
ImmunityBio, Inc. (IBRX)